T1	Participants 435 496	patients with a presumptive diagnosis of acute pyelonephritis
T2	Participants 563 572	patients.
T3	Participants 586 640	patients who satisfied the criteria for switch therapy
T4	Participants 667 674	group A
T5	Participants 695 702	group B
T6	Participants 755 867	Eighty-two patients were enrolled; 41 (50%) patients in group A and 41 (50%) patients in group B were evaluated.
